Author:
Kurnik-Łucka Magdalena,Gil Krzysztof
Publisher
Springer International Publishing
Reference176 articles.
1. Agarwal, D. P., & Goedde, H. W. (1990). Pharmacogenetics of alcohol dehydrogenase (ADH). Pharmacology & Therapeutics, 45(1), 69–83. https://doi.org/10.1016/0163-7258(90)90008-p
2. Anderson, G., Noorian, A. R., Taylor, G., Anitha, M., Bernhard, D., Srinivasan, S., & Greene, J. G. (2007). Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson’s disease. Experimental Neurology, 207(1), 4–12. https://doi.org/10.1016/j.expneurol.2007.05.010
3. Anger, W. K. (1984). Neurobehavioral testing of chemicals: Impact on recommended standards. Neurobehavioral Toxicology and Teratology, 6(2), 147–153.
4. Anlauf, M., Schäfer, M. K., Eiden, L., & Weihe, E. (2003). Chemical coding of the human gastrointestinal nervous system: Cholinergic, VIPergic, and catecholaminergic phenotypes. The Journal of Comparative Neurology, 459(1), 90–111. https://doi.org/10.1002/cne.10599
5. Antkiewicz-Michaluk, L., Michaluk, J., Romańska, I., Papla, I., & Vetulani, J. (2000). Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol. Journal of Neural Transmission (Vienna, Austria: 1996), 107(8–9), 1009–1019. https://doi.org/10.1007/s007020070049